Nicholas Lorusso
Stock Analyst at TD Cowen
(2.01)
# 3,074
Out of 4,382 analysts
12
Total ratings
50%
Success rate
2.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicholas Lorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMTX Immatics | Maintained: Buy | n/a | $9.79 | - | 3 | May 29, 2026 | |
| KROS Keros Therapeutics | Maintained: Hold | n/a | $10.30 | - | 2 | May 14, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $960 | $635.45 | +51.07% | 1 | May 6, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $60 → $65 | $48.42 | +34.24% | 6 | Apr 28, 2026 |
Immatics
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $9.79
Upside: -
Keros Therapeutics
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $10.30
Upside: -
Regeneron Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $960
Current: $635.45
Upside: +51.07%
Kiniksa Pharmaceuticals International,
Apr 28, 2026
Maintained: Buy
Price Target: $60 → $65
Current: $48.42
Upside: +34.24%